New Treatments And Lt3 (Liothyronine) Combinations / Alternative Therapies

dc.contributor.author	Karimova Muqima Muhammadsodikovna
dc.contributor.author	Djalalidinova Odina Odilovna
dc.date.accessioned	2026-01-21T20:51:43Z
dc.date.issued	2026-01-18
dc.description.abstract	This article reviews new approaches to the treatment of hypothyroidism, specifically the combination of levothyroxine (LT4) and liothyronine (LT3), as well as alternative therapies. The article provides an in-depth review of the limitations of LT4 monotherapy, the rationale for the addition of LT3, clinical trial results, safety issues, and future developments. The aim is to highlight more effective treatment options for patients with persistent symptoms and to emphasize the importance of personalized medicine.
dc.format	application/pdf
dc.identifier.uri	https://zienjournals.com/index.php/tjms/article/view/6675
dc.identifier.uri	10.62480/tjms.2026.vol52.pp1-2
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/112057
dc.language.iso	eng
dc.publisher	Zien Journals
dc.relation	https://zienjournals.com/index.php/tjms/article/view/6675/5410
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Texas Journal of Medical Science; Vol. 52 (2026): TJMS; 1-2
dc.source	2770-2936
dc.subject	Hypothyroidism
dc.subject	LT4 monotherapy
dc.subject	LT3 combination
dc.title	New Treatments And Lt3 (Liothyronine) Combinations / Alternative Therapies
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: muhammadsodikovna_2026_new_treatments_and_lt3_liothyronine_comb.pdf
item.page.filesection.size: 219.82 KB
item.page.filesection.format: Adobe Portable Document Format